{"name":"Elpiscience Biopharma Australia Pty. Ltd.","slug":"elpiscience-biopharma-australia-pty-ltd","ticker":"","exchange":"","domain":"","description":"Elpiscience Biopharma Australia Pty. Ltd. is a biotechnology company focused on the development of innovative therapies. The company currently has one drug, ES009, in Phase 1 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxNUlc4RU5JSHA0TnEwbGpPLWRtZ2xaNlNwS2lCOXJ4M2JLYUlpYVZCNkJINjRvd1R5bDZrX2tCNlZfNE5YcGhwS25KTVFfS25TYk5NU1N6RllxcTVfRW95ZnNTVE96MmlEQWNhWHluamJkMGxaZXZsWEpIb2NEa3Z0N0trdk0xc0RBMGF3ZmRWQWY5M3pzVTh5Y01QUGRPb2RsMjJsZTZKRDFaLXNEcW5GSmxjQTZETzZTLTJtcF9uRnoxMS1Fa2pVa2ZrbTdYUHFGa2VxaHJKcGl2TVpXcExRVXRHR3o0RTd4dlFEY0dvVWtMODhMSE8wcWl5U0N0VElLbGw4SkdWaUI?oc=5","date":"2023-12-27","type":"deal","source":"Business Wire","summary":"Elpiscience and Astellas Enter into Research Collaboration and License Agreement for Novel Bispecific Macrophage Engager - Business Wire","headline":"Elpiscience and Astellas Enter into Research Collaboration and License Agreement for Novel Bispecific Macrophage Engager","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNNmxIemcwZTA3UjZoUXNZY0hpcVlFeENPNnhhRVV5amFZSG1kWXdsdWRPTzBGZG9faXZPbXk1Y2V4ME5NWTNJenZYSklnTlFudjdUVkx3VmhiS293dXlKZTAxYmFxbkhvODdiWDNsUmtsQ1RNRUd5aHVlNlczYXpsbUhvV05leTMwT0dxQ2hRdlZJaWFwSC1kbXRSWjdBT2hF?oc=5","date":"2023-09-27","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"6 Immuno-oncology Startups Attracting the Biggest VC Cash - Genetic Engineering and Biotechnology News","headline":"6 Immuno-oncology Startups Attracting the Biggest VC Cash","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}